Daniel V Dudenkov1, Kristin C Mara2, Tanya M Petterson2, Julie A Maxson3, Tom D Thacher3. 1. Division of General Internal Medicine, Mayo Clinic, Rochester, MN. Electronic address: dudenkov.daniel@mayo.edu. 2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN. 3. Department of Family Medicine, Mayo Clinic, Rochester, MN.
Abstract
OBJECTIVE: To determine the relationship between 25-hydroxyvitamin D (25[OH]D) values and all-cause and cause-specific mortality. PATIENTS AND METHODS: We identified all serum 25(OH)D measurements in adults residing in Olmsted County, Minnesota, between January 1, 2005, and December 31, 2011, through the Rochester Epidemiology Project. All-cause mortality was the primary outcome. Patients were followed up until their last clinical visit as an Olmsted County resident, December 31, 2014, or death. Multivariate analyses were adjusted for age, sex, race/ethnicity, month of measurement, and Charlson comorbidity index score. RESULTS: A total of 11,022 individuals had a 25(OH)D measurement between January 1, 2005, and December 31, 2011, with a mean ± SD value of 30.0±12.9 ng/mL. Mean age was 54.3±17.2 years, and most were female (77.1%) and white (87.6%). There were 723 deaths after a median follow-up of 4.8 years (interquartile range, 3.4-6.2 years). Unadjusted all-cause mortality hazard ratios (HRs) and 95% CIs for 25(OH)D values of less than 12, 12 to 19, and more than 50 ng/mL were 2.6 (95% CI, 2.0-3.2), 1.3 (95% CI, 1.0-1.6), and 1.0 (95% CI, 0.72-1.5), respectively, compared with the reference value of 20 to 50 ng/mL. In a multivariate model, the interaction between the effect of 25(OH)D and race/ethnicity on mortality was significant (P<.001). In white patients, adjusted HRs for 25(OH)D values of less than 12, 12 to 19, 20 to 50, and greater than 50 ng/mL were 2.5 (95% CI, 2.2-2.9), 1.4 (95% CI, 1.2-1.6), 1.0 (referent), and 1.0 (95% CI, 0.81-1.3), respectively. In patients of other race/ethnicity, adjusted HRs were 1.9 (95% CI, 1.5-2.3), 1.7 (95% CI, 1.1-2.6), 1.5 (95% CI, 1.0-2.0), and 2.1 (95% CI, 0.77-5.5). CONCLUSION: White patients with 25(OH)D values of less than 20 ng/mL had greater all-cause mortality than those with values of 20 to 50 ng/mL, and white patients had greater mortality associated with low 25(OH)D values than patients of other race/ethnicity. Values of 25(OH)D greater than 50 ng/mL were not associated with all-cause mortality.
OBJECTIVE: To determine the relationship between 25-hydroxyvitamin D (25[OH]D) values and all-cause and cause-specific mortality. PATIENTS AND METHODS: We identified all serum 25(OH)D measurements in adults residing in Olmsted County, Minnesota, between January 1, 2005, and December 31, 2011, through the Rochester Epidemiology Project. All-cause mortality was the primary outcome. Patients were followed up until their last clinical visit as an Olmsted County resident, December 31, 2014, or death. Multivariate analyses were adjusted for age, sex, race/ethnicity, month of measurement, and Charlson comorbidity index score. RESULTS: A total of 11,022 individuals had a 25(OH)D measurement between January 1, 2005, and December 31, 2011, with a mean ± SD value of 30.0±12.9 ng/mL. Mean age was 54.3±17.2 years, and most were female (77.1%) and white (87.6%). There were 723 deaths after a median follow-up of 4.8 years (interquartile range, 3.4-6.2 years). Unadjusted all-cause mortality hazard ratios (HRs) and 95% CIs for 25(OH)D values of less than 12, 12 to 19, and more than 50 ng/mL were 2.6 (95% CI, 2.0-3.2), 1.3 (95% CI, 1.0-1.6), and 1.0 (95% CI, 0.72-1.5), respectively, compared with the reference value of 20 to 50 ng/mL. In a multivariate model, the interaction between the effect of 25(OH)D and race/ethnicity on mortality was significant (P<.001). In white patients, adjusted HRs for 25(OH)D values of less than 12, 12 to 19, 20 to 50, and greater than 50 ng/mL were 2.5 (95% CI, 2.2-2.9), 1.4 (95% CI, 1.2-1.6), 1.0 (referent), and 1.0 (95% CI, 0.81-1.3), respectively. In patients of other race/ethnicity, adjusted HRs were 1.9 (95% CI, 1.5-2.3), 1.7 (95% CI, 1.1-2.6), 1.5 (95% CI, 1.0-2.0), and 2.1 (95% CI, 0.77-5.5). CONCLUSION: White patients with 25(OH)D values of less than 20 ng/mL had greater all-cause mortality than those with values of 20 to 50 ng/mL, and white patients had greater mortality associated with low 25(OH)D values than patients of other race/ethnicity. Values of 25(OH)D greater than 50 ng/mL were not associated with all-cause mortality.
Authors: Daniel V Dudenkov; Barbara P Yawn; Sara S Oberhelman; Philip R Fischer; Ravinder J Singh; Stephen S Cha; Julie A Maxson; Stephanie M Quigg; Tom D Thacher Journal: Mayo Clin Proc Date: 2015-05 Impact factor: 7.616
Authors: Ahmad H Daraghmeh; Monica L Bertoia; Mazen O Al-Qadi; Abdulrahman M Abdulbaki; Mary B Roberts; Charles B Eaton Journal: Atherosclerosis Date: 2016-04-09 Impact factor: 5.162
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca Journal: Am J Epidemiol Date: 2011-03-23 Impact factor: 4.897
Authors: Armin Zittermann; Simona Iodice; Stefan Pilz; William B Grant; Vincenzo Bagnardi; Sara Gandini Journal: Am J Clin Nutr Date: 2011-12-14 Impact factor: 7.045
Authors: Christopher T Sempos; Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Elizabeth A Yetley; Anne C Looker; Rosemary L Schleicher; Guichan Cao; Vicki Burt; Holly Kramer; Regan L Bailey; Johanna T Dwyer; Xinli Zhang; Jaime Gahche; Paul M Coates; Mary Frances Picciano Journal: J Clin Endocrinol Metab Date: 2013-05-10 Impact factor: 5.958
Authors: Martin Gaksch; Rolf Jorde; Guri Grimnes; Ragnar Joakimsen; Henrik Schirmer; Tom Wilsgaard; Ellisiv B Mathiesen; Inger Njølstad; Maja-Lisa Løchen; Winfried März; Marcus E Kleber; Andreas Tomaschitz; Martin Grübler; Gudny Eiriksdottir; Elias F Gudmundsson; Tamara B Harris; Mary F Cotch; Thor Aspelund; Vilmundur Gudnason; Femke Rutters; Joline W J Beulens; Esther van 't Riet; Giel Nijpels; Jacqueline M Dekker; Diana Grove-Laugesen; Lars Rejnmark; Markus A Busch; Gert B M Mensink; Christa Scheidt-Nave; Michael Thamm; Karin M A Swart; Ingeborg A Brouwer; Paul Lips; Natasja M van Schoor; Christopher T Sempos; Ramón A Durazo-Arvizu; Zuzana Škrabáková; Kirsten G Dowling; Kevin D Cashman; Mairead Kiely; Stefan Pilz Journal: PLoS One Date: 2017-02-16 Impact factor: 3.240
Authors: Tom D Thacher; Daniel V Dudenkov; Kristin C Mara; Julie A Maxson; Chung-Il Wi; Young J Juhn Journal: J Steroid Biochem Mol Biol Date: 2019-11-18 Impact factor: 4.292
Authors: Patrick J McCullough; William P McCullough; Douglas Lehrer; Jeffrey B Travers; Steven J Repas Journal: Nutrients Date: 2021-04-29 Impact factor: 5.717
Authors: Pawel Pludowski; William B Grant; Jerzy Konstantynowicz; Michael F Holick Journal: Front Endocrinol (Lausanne) Date: 2019-05-29 Impact factor: 5.555
Authors: Casey R Johnson; Daniel V Dudenkov; Kristin C Mara; Philip R Fischer; Julie A Maxson; Tom D Thacher Journal: Mayo Clin Proc Date: 2021-08 Impact factor: 11.104
Authors: Alicia K Heath; Iris Y Kim; Allison M Hodge; Dallas R English; David C Muller Journal: Int J Environ Res Public Health Date: 2019-01-29 Impact factor: 3.390